Mamand, Sami <br/><br/>
Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma.  [electronic resource] 

 -  Scientific reports  09 2018 
 - 14216 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-018-32634-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Cell Differentiation--drug effects<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Chemokine CXCL12--metabolism<br/>Humans<br/>Jurkat Cells<br/>Lymphoma, T-Cell, Peripheral--drug therapy<br/>Phosphorylation--drug effects<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Receptors, CXCR4--metabolism<br/>Signal Transduction--drug effects<br/>T-Lymphocytes, Helper-Inducer--drug effects